Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joana Mesquita is active.

Publication


Featured researches published by Joana Mesquita.


Journal of Endocrinological Investigation | 2011

Assessment of body fat composition disturbances by bioimpedance analysis in HIV-infected adults

Paula Freitas; Davide Carvalho; Ana Cristina Santos; Joana Mesquita; Flora Correia; S. Xerinda; Rui Marques; Esteban Martínez; António Sarmento; José Luís Medina

HIV-lipodystrophy syndrome is characterized by different patterns of body fat distribution (BFD) which are identified by clinical and body composition (BC) assessment, including bioimpedance analysis (BIA). Our aim was to compare BC in HIV-infected patients on combination antiretroviral therapy (cART) according to 4 distinct phenotypes of BFD (G1-no lipodystrophy, G2-isolated central fat accumulation, G3-lipoatrophy, G4-mixed forms of lipodystrophy) and assessed factors associated with them. Anthropometry and BIA were performed in 344 HIV-1 patients. G2 and G4 phenotype patients had significantly higher fat mass (FM) but no differences were observed in fat-free mass (FFM) and total body water among the 4 phenotypes. Significant negative associations were found between the presence of lipoatrophy and female gender, body mass index (BMI), waist (WC), hip (HC) and thigh circumferences, and total body FM estimated by BIA. After adjustment for gender, cART duration and BMI, G3 had significant lower WC [odds ratio (OR)=0.84; 0.78–0.90] and HC (OR=0.88; 0.81–0.96) mean. Independently of gender, cART duration and BMI, G2 remained significantly associated with higher WC (OR=1.11; 1.05–1.18) and HC (OR=1.15; 1.07–1.23) mean, and with FM estimated by BIA [FM as %, OR=1.17 (1.09–1.26); and FM as kg, OR=1.15 (1.06–1.25)]. There was a significant positive association between G4 and female gender (OR=1.66; 1.01–2.75), BMI (OR=1.10; 1.04–1.17) and WC (OR=1.15; 1.09–1.21). The similar FFM along the BFD spectrum describes the actual BC of these patients without sarcopenia. In a clinical setting, BIA is an easy and useful tool to evaluate fat mass and FFM and gives us a picture of BC that was not possible with anthropometry.


Prostate Cancer and Prostatic Diseases | 2002

No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.

A dos Santos; Marcelo Lima Ribeiro; Joana Mesquita; A B Carvalho-Salles; C Hackel

CYP17 gene encodes the enzyme cytochrome p450c17α, which mediates two steps in the steroid biosynthesis pathway. Steroid hormones are believed to play a key role in the etiology of prostate cancer. A polymorphic T→C transition in the 5′ promoter region of CYP17 creates an additional Sp1-type (CCACC box) promoter site (allele A2). We have evaluated the genotypic and allelic distribution of this polymorphism among 92 prostate cancer patients in order to assess risk by comparison with a population-based series of 200 healthy individuals from Brazil. Our results provide no evidence for an association between prostate cancer risk and CYP17 T/C polymorphism.


BMC Infectious Diseases | 2012

Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance

Paula Freitas; Davide Carvalho; Ana Cristina Santos; Joana Mesquita; Maria João Matos; António J. Madureira; Esteban Martínez; António Sarmento; José Luís Medina

IntroductionCombined antiretroviral therapy (cART) in the treatment of HIV-1 infection has been associated with complications, including lipodystrophy, hyperlipidaemia, insulin resistance (IR) and diabetes.AimsTo compare the prevalence of glucose homeostasis disturbances and IR in HIV patients on cART according to the presence of lipodystrophy (defined clinically and by Fat Mass Ratio) and different patterns of fat distribution and to establish their associations.DesignCross-sectional cohort study.MethodsWe evaluated body composition and IR and insulin sensitivity indexes in 345 HIV-infected adults.ResultsPatients with clinical lipodystrophy (CL) had higher plasma glucose levels than patients without CL, without significant differences in plasma insulin levels, A1c, HOMA-IR, HOMA-B, QUICKI, or MATSUDA index. Patients with lipodystrophy defined by FMR had higher plasma glucose and insulin levels, A1c, HOMA-IR, QUICKI and MATSUDA than patients without lipodystrophy, without differences in HOMA-B. Higher insulin resistance (HOMA-IR ≥ 4) was present in patients with FMR-defined lipodystrophy. Patients with FMR-defined lipodystrophy had a higher prevalence of IFG, IGT and DM than patients without lipodystrophy. Significant associations between HOMA-IR and total, central and central/peripheral fat evaluated by CT at abdominal level were found and no association between HOMA-IR and peripheral fat. Association between HOMA-IR and total and trunk fat but no association with leg and arm fat (evaluated by DXA) was found.ConclusionsIR and glucose disturbances were significantly increased in patients with FMR-defined lipodystrophy. FMR lipodystrophy definition seems to be a more sensitive determinant of insulin resistance and glucose disturbances than clinical definition.


Endocrinología y Nutrición | 2010

Trauma and the endocrine system

Joana Mesquita; Ana Varela; José Luís Medina

The endocrine system may be the target of different types of trauma with varied consequences. The present article discusses trauma of the hypothalamic-pituitary axes, adrenal glands, gonads, and pancreas. In addition to changes in circulating hormone levels due to direct injury to these structures, there may be an endocrine response in the context of the stress caused by the trauma.


Endocrinología y Nutrición | 2012

Thyroid carcinoma in children and adolescents: A retrospective review

Filipa Neiva; Joana Mesquita; Susana Paco Lima; Maria João Matos; Carla Costa; Cintia Castro-Correia; Manuel Fontoura; Sofia Martins

OBJECTIVE To describe clinical presentation, preoperative study, intervention, histology, surgical complications and follow-up characteristics, and survival in patients with thyroid carcinoma (TC) with less than 18 years at presentation. MATERIAL AND METHODS retrospective analysis of clinical data of all children and adolescents followed in S. João Hospital from January 1, 2000 to March 31, 2010 with histologic diagnosis of TC. RESULTS Twenty-three patients were identified, 19 girls, and 4 boys. Median age at presentation was 17.0 years. Annual incidence was 2.3 cases/year. The main presenting symptom was a solitary thyroid nodule (60.8%). Three (13%) patients had risk factors for TC, 2 of the 3 had previous cervical irradiation. The other was a smoker. Total thyroidectomy was performed in 16 (69.6%), and 10 patients underwent a second surgical procedure. Four (17.4%) patients had postoperative complications. Histologic examination revealed differentiated TC in all, papillary thyroid carcinoma (PTC) in 86.9%, follicular carcinoma in the remaining. All patients received thyroxine suppressive therapy and 20 underwent therapeutic radioactive iodine (131I). During follow-up (7.1 years), 7 out of the 23 patients presented new metastases and needed new treatment. All patients are currently alive. CONCLUSIONS TC is a reality in pediatric population, thyroid routine examination should take part in all clinical examination in children and adolescents.


Endocrine Abstracts | 2018

Macroprolactinemia diagnosed in a patient evaluated for primary infertility

Claudia Nogueira; Filipe Cunha; Ivan Ferreira; Joana Mesquita


Endocrine Abstracts | 2018

Bilateral macronodular adrenal hyperplasia with autonomous cortisol secretion

Claudia Nogueira; Filipe Cunha; Pedro Souteiro; Sofia Castro Oliveira; Joana Mesquita


Archive | 2012

Association between hyperuricemia and metabolic syndrome

Sandra Belo; P. Freitas; Joana Mesquita; Celestino Neves; Eva Lau; Joana Queiros; Ana Varela; Flora Correia; Davide Carvalho


Archive | 2011

Associação entre hiperuricemia e síndrome metabólica

Sandra Belo; Ana Rute Neves; Cesar Esteves; Eva Lau; Joana Mesquita; Rui Poínhos; Paula Freitas; Ana Varela; Joana Queiroz; Flora Correia; Davide Carvalho


13th European Congress of Endocrinology | 2011

Diabetes insipidus in the context of sarcoidosis: a case report

Joana Mesquita; Pedro Pereira Rodrigues; Sandra Belo; A Sousa; Ana Varela; Angela Magalhaes; JoseLuis Castedo; Natália Melo; Patricia Mota; Davide Carvalho

Collaboration


Dive into the Joana Mesquita's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge